| Estimation and inference of predictive discrimination for survival outcome risk prediction models. |
35061146
|
Li R, Ning J, Feng Z |
Lifetime Data Anal |
2022 |
PLCO |
| Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. |
34995129
|
Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM |
J Clin Oncol |
2022 |
PLCO |
| Surgical Outcomes in the National Lung Screening Trial Compared With Contemporary Practice. |
35007506
|
Savitch SL, Zheng R, Abdelsattar ZM, Barta JA, Okusanya OT, Evans NR, Grenda TR |
Ann Thorac Surg |
2022 |
NLST |
| Incidence of Head and Neck Cancer With Lung Cancer Screening: Secondary Analysis of a Randomized Controlled Trial. |
34984679
|
Jassal JS, Grauer JS, Cramer JD |
Laryngoscope |
2022 |
NLST |
| Big-Hypergraph Factorization Neural Network for Survival Prediction From Whole Slide Image. |
34982683
|
Di D, Zhang J, Lei F, Tian Q, Gao Y |
IEEE Trans Image Process |
2022 |
NLST |
| Inflammatory potential of diet and colorectal carcinogenesis: a prospective longitudinal cohort. |
35136208
|
Li Z, Wang K, Shivappa N, Hébert JR, Chen H, Liu H, Jiang X |
Br J Cancer |
2022 |
PLCO |
| Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial. |
35112050
|
He S, Berndt SI, Kunzmann AT, Kitahara CM, Huang WY, Barry KH |
JNCI Cancer Spectr |
2022 |
PLCO |
| Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. |
35113855
|
Yarmolinsky J, Díez-Obrero V, Richardson TG, Pigeyre M, Sjaarda J, Paré G, Walker VM, Vincent EE, Tan VY, Obón-Santacana M, Albanes D, Hampe J, Gsur A, Hampel H, Pai RK, Jenkins M, Gallinger S, Casey G, Zheng W, Amos CI, International Lung Cancer Co… |
PLoS Med |
2022 |
PLCO |
| Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. |
35048991
|
Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, Tsilidis KK, Barroso I, Chen J, Frayling TM, Bull CJ, Vincent EE, Cotterchio M, Gruber SB, Pai RK, Newcomb PA, Perez-Cornago A, van Duijnhoven FJB, Van Guelpen B, Vodicka… |
J Natl Cancer Inst |
2022 |
PLCO |
| Detection and staging of chronic obstructive pulmonary disease using a computed tomography-based weakly supervised deep learning approach. |
35201409
|
Sun J, Liao X, Yan Y, Zhang X, Sun J, Tan W, Liu B, Wu J, Guo Q, Gao S, Li Z, Wang K, Li Q |
Eur Radiol |
2022 |
NLST |
| AI-Driven Model for Automatic Emphysema Detection in Low-Dose Computed Tomography Using Disease-Specific Augmentation. |
35182291
|
Nagaraj Y, Wisselink HJ, Rook M, Cai J, Nagaraj SB, Sidorenkov G, Veldhuis R, Oudkerk M, Vliegenthart R, van Ooijen P |
J Digit Imaging |
2022 |
NLST |
| Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. |
35351104
|
Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M |
BMC Urol |
2022 |
PLCO |
| Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data. |
35319912
|
Hammer MM, Hunsaker AR |
AJR Am J Roentgenol |
2022 |
NLST |
| Developing an understanding of artificial intelligence lung nodule risk prediction using insights from the Brock model. |
35238972
|
Chetan MR, Dowson N, Price NW, Ather S, Nicolson A, Gleeson FV |
Eur Radiol |
2022 |
NLST |
| IPRS: Leveraging Gene-Environment Interaction to Reconstruct Polygenic Risk Score. |
35401709
|
Tang Y, You D, Yi H, Yang S, Zhao Y |
Front Genet |
2022 |
PLCO |
| Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. |
35365600
|
Chang VC, Khan AA, Huang WY, Katki HA, Purdue MP, Landgren O, Hofmann JN |
Blood Cancer J |
2022 |
PLCO |
| Alu Retroelement Copy Number and Lung Cancer Risk in the Prospective Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. |
35609672
|
Wong JYY, Cawthon R, Hu W, Ezennia S, Gadalla SM, Breeze C, Blechter B, Freedman ND, Huang WY, Hosgood HD, Seow WJ, Bassig BA, Rahman ML, Hayes RB, Rothman N, Lan Q |
Chest |
2022 |
PLCO |
| Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer. |
35583137
|
Loftfield E, Falk RT, Sampson JN, Huang WY, Hullings A, Murphy G, Weinstein SJ, Albanes D, Freedman ND, Sinha R |
JNCI Cancer Spectr |
2022 |
PLCO |
| Association Between Diabetes Risk Reduction Diet and Lung Cancer Risk in 98,159 Participants: Results From a Prospective Study. |
35574372
|
Zhang Y, Zhong G, Zhu M, Chen L, Wan H, Luo F |
Front Oncol |
2022 |
PLCO |
| Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. |
35534235
|
In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M |
Cancer Epidemiol Biomarkers Prev |
2022 |
PLCO |
